68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label positron emission tomography/computed tomography ( PET/CT) study to
investigate the diagnostic performance and evaluation efficacy of 68Ga-BNOTA-PRGD2 in
rheumatoid arthritis (RA) patients. A single dose of nearly 111 MBq 68Ga-BNOTA-PRGD2 (≤ 40 µg
BNOTA-PRGD2) will be intravenously injected into patients with RA. Visual and
semiquantitative method will be used to assess the PET/CT images. Whole body 18F-FDG PET/CT
will be performed for comparison.